DALLAS, Oct. 11, 2007 (PRIME NEWSWIRE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site is initiating Profile Coverage of Advanced Medical Isotope Corporation (Pink Sheets:ADMD). Advanced Medical Isotope Corporation is engaged in the development of advanced production systems and processes for bringing previously unavailable medical isotopes to the marketplace and advancing systems for local product production. The field of nuclear medicine has routinely utilized radioisotopes in the diagnosis of disease while new processes are being pioneered for the targeted treatment of diseases such as cancer in preference to surgical techniques. Advanced Medical Isotopes Corporation products support the accessibility to these less invasive therapeutic processes by advancing systems for lower cost production and improving supply availability of medical isotopes to hospitals and clinical treatment centers.
Advanced Medical Isotope Corporation has recently licensed, from a U.S. National Laboratory, the rights to an advanced design compact system suitable for production of a series of medical radioisotopes used in advanced medical imaging diagnostic processes, such as Positron Emission Tomography or PET machines and recent advances in therapy processes used to treat life-threatening diseases, such as prostate cancer and rheumatoid arthritis. AMIC is in discussion on additional technologies to expand our portfolio of offered products and services.
To view the StockGuru.com Profile for Advanced Medical Isotope Corporation, please visit:
http://www.stockguru.com/profiles/admd
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit: http://www.stockguru.com/stocks.htm
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031 or email publisher@stockguru.com. Our services include our Morning, Midday, and After The Bell news releases. Additionally, we profile publicly traded companies on our web site, we do interviews with CEOs or other key executives on our web site, and we have our financial writers cover our companies.
Except for historical information contained herein, the matters set forth in this press release, such as statements relating to the company's ability to drive technological developments and the acceptance and timing of product introductions, are forward-looking statements that are subject to risks and uncertainties, including but not limited to, timely development and acceptance of new products, the impact of competitive products and pricing, the timely development and release of products by suppliers, and other risks.
Disclosure: Pentony Enterprises LLC has been compensated five thousand dollars and one hundred thousand restricted shares directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.